INS and metabolic dysfunction-associated steatotic liver disease: Because obesity is one of the main driving factors of NAFLD, in the study of probiotics to improve NAFLD, it is necessary to specifically evaluate the changes of body fat rate, TG, insulin sensitivity, fat inflammation, and various metabolic parameters to determine its function (Ahn et al., 2019).